Category

GMI News

Rolling out the red carpet for Newman Fellows

By | GMI News | No Comments

Glen Doherty, Rob Lumsden (GMI), UCD President Andrew Deeks, Ciara Egan, David Kavanagh (GMI) at the UCD Newman Fellowship Programme dinner at the RDS.

 

Rob Lumsden and David Kavanagh from GMI were on hand to celebrate the post-doctoral research across the humanities and sciences through the UCD Newman Fellowship Programme at the RDS alongside Prof. Glen Doherty from St. Vincent’s, UCD President Andrew Deeks and Ciara Egan.

Battling Dementia

By | GMI News | No Comments


pat-kenny-newstalk

GMI joins the battle to beat dementia as we formally launch our study researching Alzheimer’s disease. This issue was highlighted on The Pat Kenny Show yesterday morning featuring Professor Harry Vinters of the UCLA Brain Research Institute who also joined GMI for a talk on this important topic. Listen in to the highlights from the programme to learn more.

Cross-Border Research Study Aims to Unlock Answers to MS

By | GMI News | No Comments

 

GMI Collaborates with Hospitals in Cork, Dublin and Derry

Dublin, Ireland, 8th December 2017 – Irish life sciences company Genomics Medicine Ireland Ltd. today announced a new cross-border research collaboration that aims to identify the genetic markers that can help diagnose, predict disease severity, and identify personalised treatments for patients with Multiple Sclerosis (MS).

People with MS are being invited to participate in the research, which is the most comprehensive genomic study of MS to be undertaken on the island of Ireland. The hospitals and research centres involved in the launch of this study are: Cork University Hospital in conjunction with the Clinical Research Facility Cork; St. Vincent’s University Hospital, Dublin; Tallaght Hospital, Dublin; and Altnagelvin Hospital in conjunction with the Western Health and Social Care Trust in Derry. Read More

GMI Launches Genomic Research in IBD

By | GMI News | No Comments

Around 20,000 people in Ireland are diagnosed with inflammatory bowel diseases (IBD)[1], chronic inflammatory gastrointestinal disorders primarily affecting adults in the prime of their life. There are two major forms of IBD, Crohn’s disease (CD) and Ulcerative Colitis (UC) which are life-long conditions for which there is currently no known cause or cure.

IBD patient, Sara Byrne, Dr. Sean Ennis, Prof. Glen Doherty and Research Nurse, Doireann Dickinson at the IBD Genomics Study launch at St. Vincent’s Hospital.

Onset is typically in childhood or in young adults so IBD has potential to impact educational performance and work productivity, as well as quality of life. Crohn’s Disease is associated with increased mortality in the Irish population[2] and there is an increased risk of colon cancer to people with either Crohn’s disease or Ulcerative Colitis. Ireland has one of the highest rates of Colitis in the world.

Read More